gamma-aminobutyric acid has been researched along with Hallucination of Body Sensation in 20 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Excerpt | Relevance | Reference |
---|---|---|
"A case of probable gabapentin-induced visual hallucinations in a patient with no psychiatric history is reported." | 7.83 | Visual hallucinations associated with gabapentin use. ( Derkits, ME; Parsons, KA, 2016) |
"A 65-year-old woman with no psychiatric history developed visual hallucinations while taking gabapentin five times daily." | 7.83 | Visual hallucinations associated with gabapentin use. ( Derkits, ME; Parsons, KA, 2016) |
" One month later, she reported that she had self-reduced the gabapentin dosage to 300 mg once daily, after which she noticed improvement in her daytime sleepiness and fatigue and experienced one hallucination approximately one week after the dosage reduction." | 5.43 | Visual hallucinations associated with gabapentin use. ( Derkits, ME; Parsons, KA, 2016) |
"A case of probable gabapentin-induced visual hallucinations in a patient with no psychiatric history is reported." | 5.43 | Visual hallucinations associated with gabapentin use. ( Derkits, ME; Parsons, KA, 2016) |
"Charles Bonnet syndrome is a condition characterised by the presence of visual hallucinations in patients having visual impairment most commonly reported in the seventh decade." | 5.39 | Pregabalin in the treatment of Charles Bonnet syndrome. ( Bokdawala, RA; Sawant, NS, 2013) |
"We found lower GABA+/creatine in PD with visual hallucinations (0." | 3.88 | Reduced occipital GABA in Parkinson disease with visual hallucinations. ( Allan, CL; Blamire, AM; Collerton, D; Firbank, MJ; Killen, A; Murphy, N; Parikh, J; Taylor, JP, 2018) |
"A case of probable gabapentin-induced visual hallucinations in a patient with no psychiatric history is reported." | 3.83 | Visual hallucinations associated with gabapentin use. ( Derkits, ME; Parsons, KA, 2016) |
"A 65-year-old woman with no psychiatric history developed visual hallucinations while taking gabapentin five times daily." | 3.83 | Visual hallucinations associated with gabapentin use. ( Derkits, ME; Parsons, KA, 2016) |
"Most models of schizophrenia are based on basal ganglia-thalamocortical (BGTC) neuronal circuits or brain structures that project to them." | 2.44 | Are anticorrelated networks in the brain relevant to schizophrenia? ( Williamson, P, 2007) |
"To investigate the relationship between visual hallucinations in Parkinson disease (PD) and levels of γ-aminobutyric acid (GABA) in the primary visual cortex." | 1.48 | Reduced occipital GABA in Parkinson disease with visual hallucinations. ( Allan, CL; Blamire, AM; Collerton, D; Firbank, MJ; Killen, A; Murphy, N; Parikh, J; Taylor, JP, 2018) |
"We found lower GABA+/creatine in PD with visual hallucinations (0." | 1.48 | Reduced occipital GABA in Parkinson disease with visual hallucinations. ( Allan, CL; Blamire, AM; Collerton, D; Firbank, MJ; Killen, A; Murphy, N; Parikh, J; Taylor, JP, 2018) |
" One month later, she reported that she had self-reduced the gabapentin dosage to 300 mg once daily, after which she noticed improvement in her daytime sleepiness and fatigue and experienced one hallucination approximately one week after the dosage reduction." | 1.43 | Visual hallucinations associated with gabapentin use. ( Derkits, ME; Parsons, KA, 2016) |
"A case of probable gabapentin-induced visual hallucinations in a patient with no psychiatric history is reported." | 1.43 | Visual hallucinations associated with gabapentin use. ( Derkits, ME; Parsons, KA, 2016) |
"Charles Bonnet syndrome is a condition characterised by the presence of visual hallucinations in patients having visual impairment most commonly reported in the seventh decade." | 1.39 | Pregabalin in the treatment of Charles Bonnet syndrome. ( Bokdawala, RA; Sawant, NS, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 7 (35.00) | 29.6817 |
2010's | 8 (40.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Hjelmervik, H | 1 |
Craven, AR | 1 |
Sinceviciute, I | 1 |
Johnsen, E | 1 |
Kompus, K | 1 |
Bless, JJ | 1 |
Kroken, RA | 1 |
Løberg, EM | 1 |
Ersland, L | 1 |
Grüner, R | 1 |
Hugdahl, K | 1 |
Colijn, MA | 1 |
Onofrj, M | 1 |
Gilbert, GJ | 1 |
Firbank, MJ | 1 |
Parikh, J | 1 |
Murphy, N | 1 |
Killen, A | 1 |
Allan, CL | 1 |
Collerton, D | 1 |
Blamire, AM | 1 |
Taylor, JP | 2 |
Sawant, NS | 1 |
Bokdawala, RA | 1 |
Fujishiro, H | 1 |
Nair, AG | 2 |
Shah, BR | 1 |
Gandhi, RA | 1 |
Parsons, KA | 1 |
Derkits, ME | 1 |
Khundakar, AA | 1 |
Hanson, PS | 1 |
Erskine, D | 1 |
Lax, NZ | 1 |
Roscamp, J | 1 |
Karyka, E | 1 |
Tsefou, E | 1 |
Singh, P | 1 |
Cockell, SJ | 1 |
Gribben, A | 1 |
Ramsay, L | 1 |
Blain, PG | 1 |
Mosimann, UP | 1 |
Lett, DJ | 1 |
Elstner, M | 1 |
Turnbull, DM | 1 |
Xiang, CC | 1 |
Brownstein, MJ | 1 |
O'Brien, JT | 1 |
Attems, J | 1 |
Thomas, AJ | 1 |
McKeith, IG | 1 |
Morris, CM | 1 |
Holroyd, S | 1 |
Sabeen, S | 1 |
Pedroso, JL | 1 |
Nakama, GY | 1 |
Carneiro Filho, M | 1 |
Barsottini, OG | 1 |
Gibson, KM | 1 |
Gupta, M | 1 |
Pearl, PL | 1 |
Tuchman, M | 1 |
Vezina, LG | 1 |
Snead, OC | 1 |
Smit, LM | 1 |
Jakobs, C | 1 |
Deng, C | 1 |
Huang, XF | 1 |
Coutin-Churchman, P | 1 |
Moreno, R | 1 |
Añez, Y | 1 |
Vergara, F | 1 |
Finucane, TE | 1 |
Williamson, P | 1 |
Gerlach, J | 1 |
Bjørndal, N | 1 |
Christensson, E | 1 |
Maeda, H | 1 |
Paulig, M | 1 |
Mentrup, H | 1 |
Garabedian-Ruffalo, SM | 1 |
Ruffalo, RL | 1 |
3 reviews available for gamma-aminobutyric acid and Hallucination of Body Sensation
Article | Year |
---|---|
The characterization of psychotic symptoms in succinic semialdehyde dehydrogenase deficiency: a review.
Topics: Adolescent; Age of Onset; Aggression; Amino Acid Metabolism, Inborn Errors; Anticonvulsants; Anxiety | 2020 |
Are anticorrelated networks in the brain relevant to schizophrenia?
Topics: Affect; Basal Ganglia; Cerebrovascular Circulation; gamma-Aminobutyric Acid; Hallucinations; Humans; | 2007 |
A theoretical and neurophysiological consideration on the pathogenesis of positive symptoms of schizophrenia: implications of dopaminergic function in the emotional circuit.
Topics: Brain; Brain Mapping; Delusions; Dopamine; Emotions; gamma-Aminobutyric Acid; Hallucinations; Humans | 1994 |
17 other studies available for gamma-aminobutyric acid and Hallucination of Body Sensation
Article | Year |
---|---|
Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
Topics: Adult; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Hallucinations; Humans; Pre | 2020 |
GABA and hallucinations in Parkinson disease: Who is that sitting on my chair?
Topics: gamma-Aminobutyric Acid; Hallucinations; Humans; Parkinson Disease; Posture; Sitting Position | 2018 |
Reduced occipital GABA in Parkinson disease with visual hallucinations.
Topics: Aged; Aged, 80 and over; Cognition Disorders; Creatine; Female; gamma-Aminobutyric Acid; Gray Matter | 2018 |
Pregabalin in the treatment of Charles Bonnet syndrome.
Topics: Analgesics; Diabetic Neuropathies; Diabetic Retinopathy; Female; gamma-Aminobutyric Acid; Hallucinat | 2013 |
Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies.
Topics: Aged; Carbamates; Dopamine Agonists; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Japan; | 2014 |
Seeing the unseen: Charles Bonnet syndrome revisited.
Topics: Aged; Amines; Awareness; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; H | 2015 |
Visual hallucinations associated with gabapentin use.
Topics: Aged; Amines; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyr | 2016 |
Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Enzyme-Linked Immunosorbent Assay; gamma- | 2016 |
Successful treatment of hallucinations associated with sensory impairment using gabapentin.
Topics: Aged, 80 and over; Amines; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; G | 2008 |
Delirium, psychosis, and visual hallucinations induced by pregabalin.
Topics: Adult; Analgesics; Delirium; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Low Back Pain; | 2012 |
Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
Topics: Adult; Aldehyde Oxidoreductases; Atrophy; Cerebellum; Chromatography, High Pressure Liquid; Chromato | 2003 |
Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia.
Topics: Adaptation, Physiological; Adult; Binding, Competitive; GABA Agonists; gamma-Aminobutyric Acid; Hall | 2006 |
Clinical correlates of quantitative EEG alterations in alcoholic patients.
Topics: Adult; Age Factors; Aged; Alcohol Withdrawal Seizures; Alcohol-Induced Disorders, Nervous System; Al | 2006 |
Neurontin for Charles Bonnet Syndrome.
Topics: Amines; Central Nervous System Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric A | 2006 |
Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesia.
Topics: Animals; Apomorphine; Chlorocebus aethiops; Diazepam; Dopamine; Drug Interactions; Dyskinesia, Drug- | 1984 |
Charles Bonnet's syndrome: complete remission of complex visual hallucinations treated by gabapentin.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Am | 2001 |
Adverse effects secondary to baclofen withdrawal.
Topics: Adult; Baclofen; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Intestinal Absorption; Mus | 1985 |